Cipla’s arm acquires 100% stake in Celeris d.o.o.

05 Dec 2013 Evaluate

Cipla’s wholly owned subsidiary - Cipla Holding B.V., has acquired 100% stake in Celeris d.o.o., Croatia. Celeris d.o.o. is the distributor of company’s products in Croatia.

Cipla focuses on development of new formulations and has a wide range of pharmaceutical products. It offers prescription drugs, bulk drugs, animal products and pesticides. It also offers a wide range of food and beverages, baked foods, oral hygiene products, detergents, room fresheners and personal care products.

The company has reported 24.79% fall in its net profit at Rs 376.03 crore for the second quarter ended September 30, 2013 as compared to Rs 500.01 crore for the same quarter in the previous year. However, total income of the company has increased by 6.59% at Rs 2411.96 crore for quarter under review as compared to Rs 2262.74 crore for the quarter ended September 30, 2012.

Cipla Share Price

1520.55 -0.65 (-0.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×